Patents by Inventor Alan Husband

Alan Husband has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160136129
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Application
    Filed: October 26, 2015
    Publication date: May 19, 2016
    Inventors: Andrew Heaton, Alan Husband
  • Patent number: 9198895
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Grant
    Filed: January 5, 2015
    Date of Patent: December 1, 2015
    Assignee: MEI Pharma, Inc.
    Inventors: Andrew Heaton, Alan Husband
  • Publication number: 20150238458
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Application
    Filed: January 5, 2015
    Publication date: August 27, 2015
    Inventors: Andrew HEATON, Alan HUSBAND
  • Patent number: 8957109
    Abstract: Chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Grant
    Filed: May 10, 2013
    Date of Patent: February 17, 2015
    Assignee: MEI Pharma, Inc.
    Inventors: Andrew Heaton, Alan Husband
  • Publication number: 20140161908
    Abstract: Novel chroman derivatives and intermediate compounds, compostions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotheraputic selective agents are described.
    Type: Application
    Filed: May 10, 2013
    Publication date: June 12, 2014
    Applicant: MEI Pharma, Inc.
    Inventors: Andrew HEATON, Alan HUSBAND
  • Patent number: 8461361
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Grant
    Filed: March 8, 2012
    Date of Patent: June 11, 2013
    Assignee: Marshall Edwards, Inc.
    Inventors: Andrew Heaton, Alan Husband
  • Publication number: 20120172424
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Application
    Filed: March 8, 2012
    Publication date: July 5, 2012
    Applicant: MARSHALL EDWARDS, INC.
    Inventors: Andrew HEATON, Alan Husband
  • Publication number: 20120114766
    Abstract: Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Application
    Filed: November 10, 2011
    Publication date: May 10, 2012
    Applicant: MARSHALL EDWARDS, INC.
    Inventors: Andrew HEATON, Alan HUSBAND
  • Patent number: 8163795
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: April 24, 2012
    Assignee: Marshall Edwards, Inc.
    Inventors: Andrew Heaton, Alan Husband
  • Publication number: 20120004296
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Application
    Filed: September 13, 2011
    Publication date: January 5, 2012
    Applicant: MARSHALL EDWARDS, INC
    Inventors: Andrew Heaton, Alan Husband
  • Patent number: 8084628
    Abstract: Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Grant
    Filed: August 31, 2009
    Date of Patent: December 27, 2011
    Assignee: Marshall Edwards, Inc.
    Inventors: Andrew Heaton, Alan Husband
  • Patent number: 8080675
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: December 20, 2011
    Assignee: Marshall Edwards, Inc.
    Inventors: Andrew Heaton, Alan Husband
  • Publication number: 20090317490
    Abstract: Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Application
    Filed: August 31, 2009
    Publication date: December 24, 2009
    Applicant: Novogen Research PTY LTD.
    Inventors: Andrew HEATON, Alan HUSBAND
  • Patent number: 7601855
    Abstract: Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: October 13, 2009
    Assignee: Novogen Research Pty Ltd
    Inventors: Andrew Heaton, Alan Husband
  • Publication number: 20090233999
    Abstract: Isoflavone compounds and analogues thereof, compositions containing same and therapeutic methods of treatment involving same are described.
    Type: Application
    Filed: November 6, 2008
    Publication date: September 17, 2009
    Applicant: NOVOGEN RESEARCH PTY LTD
    Inventors: ANDREW HEATON, NARESH KUMAR, GRAHAM EDMUND KELLY, ALAN HUSBAND
  • Patent number: 7488494
    Abstract: Isoflavone compounds are described and recommended as therapeutic agents. Exemplified and preferred compounds are (a). Indications show compounds have good competitive binding to estrogen receptors.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: February 10, 2009
    Assignee: Novogen Research Pty Ltd.
    Inventors: Andrew Heaton, Naresh Kumar, Graham Edmund Kelly, Alan Husband
  • Publication number: 20080069900
    Abstract: This invention relates to combination therapies involving anticancer chemotherapeutic agents and isoflavones or analogues thereof. The invention flier relates to compounds, compositions, methods and therapeutic uses involving, containing, comprising, including and/or for preparing platinum-isoflavonoid complexes suitable for use in the combination therapies of the invention.
    Type: Application
    Filed: April 5, 2007
    Publication date: March 20, 2008
    Inventors: Graham Kelly, Alan Husband, David Brown, Harriet Kluger, Gil Mor
  • Publication number: 20080038387
    Abstract: A method for the treatment, prophylaxis, amelioration or prevention of disorders associated with abnormally high activity of steroidal estrogens, which includes administering to a human subject a composition comprising an isoflavone-containing extract of clover or chick peas, said extract comprising primarily biochanin, or a ration of biochanin to one or more of the isoflavones from the group formononetin, daidzein and genistein in the range of from about 2:1 to about 5:1, optionally in association with one or more pharmaceutically acceptable carriers, excipients, auxiliaries and/or diluents is described. Also described are compositions and uses comprising the isoflavone containing extracts.
    Type: Application
    Filed: April 17, 2007
    Publication date: February 14, 2008
    Applicant: NOVOGEN RESEARCH PTY LTD
    Inventors: Graham Kelly, Alan Husband
  • Publication number: 20080014249
    Abstract: Isoflavone compounds are described and recommended as therapeutic agents. Exemplified and preferred compounds are (a). Indications show compounds have good competitive binding to estrogen receptors. This is exemplified.
    Type: Application
    Filed: September 17, 2007
    Publication date: January 17, 2008
    Inventors: Andrew Heaton, Naresh Kumar, Graham Kelly, Alan Husband
  • Publication number: 20060153781
    Abstract: Methods for protecting skin from UV-induced DNA mutagenic damage comprising administration of one or more of equol, dehydroequol, isoflav-3-ene and isoflavan compounds in admixture with a dermally acceptable carrier are described. Also described are methods for preventing skin cancer formation.
    Type: Application
    Filed: September 5, 2003
    Publication date: July 13, 2006
    Applicant: Novogen Research Pty Ltd, a Corporation
    Inventors: Graham Kelly, Alan Husband, Cath Walker